BNT162b2 vaccine effectiveness in preventing SARS-CoV-2 infection and severe disease

The BNT162b2 vaccine’s effectiveness in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

WHO adds MVA-BN vaccine to prequalification list as first vaccine against mpox

The World Health Organization (WHO) has announced the MVA-BN vaccine as the first vaccine against mpox to be added to its prequalification list.

September 13, 2024

MedPod Today: Big Medical Bill; GLP-1 Agonist Plateau; Grateful Patient Fundraising

The following is a transcript of the podcast episode: Rachael Robertson: Hey everybody. Welcome to MedPod Today, the podcast series where MedPage Today reporters share

September 30, 2023

DEFENCE THERAPEUTICS AWARDED BROAD U.S. PATENT COVERING ITS PIONEERING CANCER-KILLING ACCUTOX® TECHNOLOGY – Biotech Investments

EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous DEFENCE THERAPEUTICS AWARDED BROAD U.S. PATENT COVERING ITS PIONEERING CANCER-KILLING ACCUTOX® TECHNOLOGY 04.03.2024 / 08:00 CET/CEST The

March 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.